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Background: Neoplastic transformation of cultured cells by a number of oncogenes such as src suppresses gap
junctional, intercellular communication (GJIC); however, the role of Src and its effector Signal transducer and
activator of transcription-3 (Stat3) upon GJIC in non small cell lung cancer (NSCLC) has not been defined.
Immunohistochemical analysis revealed high Src activity in NSCLC biopsy samples compared to normal tissues.
Here we explored the potential effect of Src and Stat3 upon GJIC, by assessing the levels of tyr418-phosphorylated
Src and tyr705-phosphorylated Stat3, respectively, in a panel of NSCLC cell lines.
Methods: Gap junctional communication was examined by electroporating the fluorescent dye Lucifer yellow into
cells grown on a transparent electrode, followed by observation of the migration of the dye to the adjacent,
non-electroporated cells under fluorescence illumination.
Results: An inverse relationship between Src activity levels and GJIC was noted; in five lines with high Src activity
GJIC was absent, while two lines with extensive GJIC (QU-DB and SK-LuCi6) had low Src levels, similar to a non-
transformed, immortalised lung epithelial cell line. Interestingly, examination of the mechanism indicated that
Stat3 inhibition in any of the NSCLC lines expressing high endogenous Src activity levels, or in cells where Src was
exogenously transduced, did not restore GJIC. On the contrary, Stat3 downregulation in immortalised lung
epithelial cells or in the NSCLC lines displaying extensive GJIC actually suppressed junctional permeability.
Conclusions: Our findings demonstrate that although Stat3 is generally growth promoting and in an activated
form it can act as an oncogene, it is actually required for gap junctional communication both in nontransformed
lung epithelial cells and in certain lung cancer lines that retain extensive GJIC.
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Gap junctions are plasma membrane channels that provide
a path of direct communication between the interiors of
neighboring cells and are formed by the connexin (Cx)
family of proteins. An increase in cell proliferation corre-
lates with a reduction in gap junctional, intercellular com-
munication (GJIC [1]). In fact, a number of oncogene
products such as v-Src [2], the polyoma virus middle
Tumor antigen, an oncogene which acts by activating Src* Correspondence: raptisl@queensu.ca
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reproduction in any medium, provided the orfamily kinases (mT [3,4]), the chaperone Hsp90N [5], vRas
[6,7] and others have been shown to interrupt junctional
communication.
Extensive evidence has indicated that expression of the
Src tyrosine kinase leads to gap junction closure, through
phosphorylation of the ubiquitous connexin, Cx43. Src
exerts its effect either through direct tyrosine phosphory-
lation of Cx43, or indirectly, through activation of the
serine/threonine, Erk1/2 or protein kinase C family kinases
[8]. Examination of levels of tyr-418 phosphorylated, ie acti-
vated Src in a number of Non Small Cell Lung Cancer
(NSCLC) biopsies previously showed the presence of higher
Src activity than the surrounding, non-tumor lung tissueLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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NSCLC lines and primary cells which may express other
oncogenes in addition to Src, or different levels of Src
effectors, remains to be determined.
The Signal Transducer and Activator of transcription-3
(Stat3), an important Src downstream effector, is a cytoplas-
mic transcription factor. Following phosphorylation on tyr-
705 by Src, as well as by growth factor or cytokine
receptors such as the IL6 family, Stat3 normally dimerises
through a reciprocal SH2 domain-phosphotyrosine inter-
action and translocates to the nucleus, where it induces
the transcription of specific genes [11]. The effect of Src
upon Stat3 activation in NSCLC lines is at present un-
clear. Examination of Stat3 levels in certain NSCLC lines
demonstrated that Src is a major Stat3 activator, transdu-
cing signals from EGFR and IL6 that lead to apoptosis
inhibition [12], while in another report [13] Src inhibition
in different NSCLC lines was found to actually increase
Stat3-ptyr705. However, we and others previously
demonstrated that cell-to-cell adhesion, as observed
at confluence of cultured cells, causes a dramatic in-
crease in Stat3 activity levels in a number of cellular
systems ([14-16] reviewed in [17]); for this reason, cell
density must be taken into account in the examination of
the effect of different factors such as Src upon Stat3 activity
levels. In the present report this was achieved by measuring
Stat3-ptyr705 phosphorylation and activity levels at a range
of densities.
We previously assessed GJIC in a number of lung cancer
lines [18]. In the present work GJIC was examined using an
apparatus where cells were grown on a glass slide, half of
which was coated with electrically conductive, optically
transparent, indium-tin oxide. An electrode was placed on
top of the cells and an electrical pulse, which opens tran-
sient pores on the plasma membrane, was applied in the
presence of the fluorescent dye, Lucifer yellow. Although
this technique is adequate for a number of lines, the turbu-
lence generated as the electrode is removed can cause cell
detachment, which makes GJIC examination problematic.
Here, we revisited the question of GJIC levels in lung
cancer lines using an improved technique, where the upper
electrode is eliminated. This approach is valuable for the
electroporation of tumor-derived lines especially at high
densities, where cell adhesion to the substratum may be
weak. Interestingly, the results revealed that cell density per
se triggers a dramatic increase in both Cx43 levels and
GJIC. Two NSCLC lines, QU-DB and SK-LuCi6 were
found to have extensive GJIC, similar to control, nontrans-
formed lung epithelial cells, while GJIC in five other lines
was very low or undetectable. Investigation of the mechan-
ism of gap junction closure revealed an inverse relation
between Src activity levels and GJIC. Further studies led to
the discovery that, unlike Ras inhibition in Src-transformed
fibroblasts [19], Stat3 inhibition in NSCLC lines with highSrc activity does not restore GJIC. On the contrary, Stat3
inhibition in lines displaying extensive GJIC (QU-DB,
SK-LuCi6) suppressed junctional permeability, indicating
that Stat3 activity is actually required for the maintenance
of gap junction function in these lung cancer lines.Results
Cell density upregulates GJIC and connexin-43 protein
levels
A number of reports showed that gap junction function
is dependent upon cell to cell contact and the assembly
of adherens junctions [20,21]. Since the opportunity for
engagement of cadherins, key components of adherens
junctions, is expected to increase with cell density, we
examined the effect of cell density upon GJIC. To this
effect, we took advantage of the nontransformed mouse
lung epithelial type II line, E10 that has extensive GJIC,
an even and flat morphology and good adhesion to the
substratum even at high densities [22] (Figure 1A). In
addition, unlike nontransformed human lung lines such
as NL-20 [23], E10 cells can be grown in the absence of
growth factors that could affect GJIC. Cells were plated in
electroporation chambers and when 90% confluent or at 3
days post-confluence Lucifer yellow was electroporated and
the movement of the dye through gap junctions observed
under fluorescence and phase contrast illumination
(see Methods). The results are presented as the average
number of cells where dye transfered, per cell loaded with
the dye by electroporation (GJIC). As shown in Figure 1B,
a-c, although cells at 90% confluence did display some gap
junction transfer (GJIC ~1.5), GJIC increased to ~6 at 3
days post-confluence (Figure 1B, d-f), indicating that cell
density causes a dramatic increase in GJIC (Table 1,A).
We next examined the levels of Cx43, a widely expressed
gap junction protein, at different cell densities. Cells were
plated in plastic petri dishes at a confluence of 80% and at
different times up to 5 days post confluence, total protein
extracts were probed for Cx43 by Western blotting. As
shown in Figure 1C, cell density caused a dramatic increase
in Cx43 levels, which plateaued at ~3 days post-confluence
(lane 1 vs 5).GJIC and connexin-43 in NSCLC lines and freshly
explanted tumor cells
In light of the above findings, we examined GJIC
levels at different densities up to 4 days post-
confluence in a panel of human lung cancer lines
[18]. Two NSCLC lines, QU-DB (Figure 2A, a-c) and
SK-LuCi6 (Table 1,A) displayed extensive GJIC at
their peak density, while five NSCLC lines had very
low GJIC (e.g. A549, Figure 2B, a-c, and Table 1,B).
In addition, primary cells explanted and cultured from
a moderately differentiated adenosquamous carcinoma
Figure 1 Cell density increases GJIC and Cx43 levels. A. Immortalised lung epithelial E10 cells were plated in 3 cm plastic petri dishes, grown
to different densities and photographed under phase-contrast illumination. Magnification: 240x. B. E10 cells were plated in electroporation
chambers and subjected to a pulse in the presence of Lucifer yellow when 90% confluent (a-c) or 3 days after confluence (d-f) and
photographed under phase-contrast (a, d), fluorescence (b, e) or combined (c, f) illumination (see Methods, Figure 7). Arrows point to the
position of the edge of the electroporated area. In a, b, d and e, stars mark cells loaded with the dye at the edge of the electroporated area and
dots mark cells into which the dye was transferred through gap junctions. Magnification: 240x C. E10 cells were seeded in plastic petri dishes and
when they reached the indicated densities, detergent cell extracts were probed for Cx43 (top) or GAPDH (bottom) as a control.
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oma, and an adenocarcinoma (Table 2) had no GJIC.
Examination of Cx43 levels showed that QU-DB cells
had levels similar to E10, which increased dramatically
with cell density, while Cx43 levels in A549 cells were
almost undetectable, at any cell density (Figure 4A). SK-
LuCi6 cells had levels similar to QU-DB, while all other
NSCLC lines examined had very low Cx43 levels at all
densities tested (not shown). The above data taken
together indicate that, besides nontransformed epithelial
cells, cell density causes a dramatic increase in GJIC
and Cx43 protein levels in two lung carcinoma lines
which display extensive GJIC. Nevertheless, the majority
of lung cancer lines examined (5/7) had very low or no
detectable gap junctional communication, even at high cell
densities (Table 1,B).Src activity and GJIC suppression in NSCLC lines
We next examined Src-tyr418 phosphorylation, as an
indication of Src activity. As shown in Figure 5A and C,
A549 cells displayed high Src-ptyr418 levels, similar to the
levels in SK-LuCi6 or E10 cells expressing activated Src by
retroviral transduction (lines SK-LuCi6-Src, E10-Src,
respectively, Figure 5C, lanes 1 vs 3 and Table 1,B), while
Src-ptyr418 levels in QU-DB cells were low (Figure 5A,
lanes 5-8), similar to E10 (Figure 5B, lanes 5 and 6). Lines
CALU-1, SW-900, CALU-6 and SK-Lu1 had Src-ptyr418
levels comparable to SK-LuCi6-Src (Figure 5B, lanes 1-3
vs 7 and Table 1,B), while SK-LuCi6 had low levels, similar
to QU-DB (Figure 5B, lanes 4-5). Examination of gap
junctional communication revealed that five lines with
high Src-ptyr418 (A549, CALU-1, SW-900, CALU-6,
LuCi-1) had very low or no detectable GJIC (Figure 2B,
Table 1 Effect of Stat3 downregulation upon GJIC
A. Cells with extensive junctional communication
Cell line Treatmentα Srcβ(%) Stat3β (%) GJICγ
50% 100+3d 90% 100+3d
E10 - 6±1 9±3 26±9 1.5±0.5 6.0±1
“ DMSO 6±1 9±3 30±8 - 6.0±1
“ CPA7 5±1 2±1.1 3±1 - 0.2±0.1
“ sh-Stat3 N/A 6±1.1 8±2 - 1.0±0.2
QU-DB - 7±1 10±2 20±4 1±0.2 6.3±1
“ DMSO 7±1 10±2 22±3 - 6.3±1
“ CPA7 5±1 2±0.5 2±0.5 - 0.2±0.1
“ sh-Stat3 N/A 5±3 8±2 - 0.8±0.2
SK-LuCi6 - 5±1 8±2 21±4 1.8±0.2 6.5±1
“ DMSO 5±1 8±2 20±5 - 6.5±1
“ CPA7 5±1.2 2.8±1.25 3±1 - 0.3±0.1
“ sh-Stat3 N/A 6±2 4±0.5 - 1±0.2
“ Jak inhib.1 5.2±0.3 4.2±1.1 5±0.5 - 0.5±0.2
“ Stat3C 5.1±1 22±9 97±10 - 8±1
B. Cells expressing activated Src
A549 - 95±11 93±12 320±32 0.1 ±0.1 0.3 ±0.1
“ DMSO 95±11 93±12 320±32 - 0.3 ±0.1
“ CPA7 93±10 8±1 12±2 - 0.1 ±0.1
“ sh-Stat3 N/A 12±3 11±4 - 0.1±0.1
E10-Src DMSO 98±12 98±15 350±28 - 0.4 ±0.2
“ CPA7 95±11 5±1 15±4 - 0.1 ±0.1
“ sh-Stat3 N/A 9±3 20±3 - 0.1±0.1
SK-LuCi6-Src DMSO 100±12 100±12 420±33 - 0.2±0.1
“ CPA7 98±10 3±1 9±1 - 0.1 ±0.1
“ sh-Stat3 N/A 11±3 17±3 - 0.3±0.1
“ sh-Stat3+Das. 4±1 6±1.1 14±3 - 0.2±0.1
SK-Lu-1 DMSO 85±5 90±11 311±23 - 1±0.2
“ CPA7 82±4 6±1 8±3 - 0.1 ±0.1
CALU-1 DMSO 96±9 100±10 290±12 - 0.1 ±0.1
“ CPA7 90±12 8±2 6±1 - 0.1 ±0.1
SW-900 DMSO 100±13 100±12 405±21 - 0.1 ±0.1
“ CPA7 96±11 12±1 11±2 - 0.1 ±0.1
CALU-6 DMSO 95±11 93±10 300±18 - 0.1 ±0.1
“ CPA7 93±10 10±1 15±5 - 0.1 ±0.1
αFor Stat3 inhibition, cells were treated with 50 μM CPA7, or the DMSO carrier for 24 hrs, or infected with a lentivirus vector expressing a Stat3-specific, shRNA
[37]. For Stat3 upregulation, cells were infected with a retroviral vector containing Stat3C. Jak inhibitor-1 was used at 5μM [16].
β Stat3-tyr705 or Src-ptyr418 levels were measured by Western blotting. Numbers represent relative values obtained by quantitation analysis. Averages of at least
three experiments ±SEM are shown. For Stat3, data from cells grown to 50% confluence or 3 days after confluence are presented [15], with the average of the
values for DMSO-treated, Src-transduced, SK-LuCi6-Src cells grown to 50% confluence taken as 100%. The transcriptional activity values obtained paralleled the
Stat3-705 phosphorylation levels indicated (Figure 4C and D, see Methods).
γGJIC was assessed by in situ electroporation at the indicated confluences (see Methods, Figure 8). Quantitation was achieved by dividing the number of cells into
which the dye had transferred through gap junctions (denoted by dots, Figure 1B and 2A), by the number of cells at the edge of the electroporated area
(denoted by stars). Numbers are averages ±SEM of at least three experiments, where transfer from more than 200 cells was examined.
N/A: Not applicable.
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Figure 2 A. Stat3 downregulation eliminates gap junctional permeability in human lung carcinoma QU-DB cells. QU-DB cells were plated
in electroporation chambers and subjected to a pulse in the presence of Lucifer yellow, following treatment with the DMSO carrier alone (a-c), or
CPA7 (d-f), or infection with the sh-Stat3 lentiviral vector (g-i) (see Methods, Figure 8). After washing away the unincorporated dye, cells from the
same field were photographed under fluorescence (b, e, h) or phase contrast (a, d, g) illumination. Cells at the edge of the conductive area
which were loaded with LY through electroporation were marked with a star, and cells at the non-electroporated area which received LY
through gap junctions were marked with a dot [4]. Arrows point to the edge of the electroporated area. c, f, i: Overlay of phase-contrast and
fluorescence. Magnification: 240 x. Note the extensive gap junctional communication in (b). B. Stat3 downregulation does not increase gap
junctional permeability in human lung carcinoma A549 cells. Same as above, A549 cells. Note the absence of GJIC, even after Stat3
downregulation (e, h).
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or E10 cells eliminated junctional permeability (E10-Src
and SK-LuCi6-Src, Table 1, B), in agreement with the
known Src effect of GJIC suppression. Conversely, the two
lines with low Src-ptyr418 levels (QU-DB and SK-LuCi6),
had high GJIC, especially at high densities (Figure 2A and
Table 1, A). Primary cells from the three tumor specimens
were found to have higher Src activity than the E10,
consistent with previous results from biopsy tissues
(Figure 3, bottom panel). Taken together, these data point
to an inverse relationship between Src activity levels and
GJIC in these NSCLC lines.
Stat3 is a positive regulator of GJIC in NSCLC lines
Stat3 is a prominent effector of the non-receptor tyro-
sine kinase Src [24]. However, Stat3 can be activated by
cytokine and membrane tyrosine kinase receptors, which
can act in a Src-independent manner [11]. Therefore, to
assess the specific contribution of Src to Stat3 activation
in the lung cancer lines, we at first examined the corre-
lation between Src-ptyr418 and Stat3-ptyr705 levels. As
shown before for a number of cell types (reviewed in
[17]), high cell density caused an increase in Stat3-ptyr705
levels in all lines (e.g. Figure 5A, lanes 1-4 and 5-8), there-
fore Stat3-ptyr705 levels were assessed at a confluence of
50% for this experiment (see Methods). The results
showed elevated Stat3-ptyr705 levels in the five lines withhigh Src-ptyr418 at all cell densities, comparable to
SK-LuCi6-Src cells (e.g. A549 vs QU-DB, Figure 5A,
lanes 1-4 vs 5-8 and Figure 5B and Table 1,B). At the
same time, QU-DB and SK-LuCi6 cells had low levels of
both Src-ptyr418 and Stat3-ptyr705 (Figure 5B). The above
data point to a correlation between Src and Stat3 activity
levels in the NSCLC lines. We next examined the effect of
Src inhibition upon Stat3-ptyr705 in the lines found to have
high Src-ptyr418. The results showed that treatment with
the Src inhibitor Dasatinib caused a dramatic reduction in
Stat3-ptyr705 (e.g. line A549, Figure 5C, and Additional
file 1: Additional data, Table Add-I). Similar results were
obtained with the PD180970 and SU6656 Src inhibitors
(see Methods). These findings indicate that Src may, in
fact, be an important Stat3 activator in these cells.
The effect of Stat3 inhibition upon GJIC in the 5 lines
with high Src activity was examined next. As shown in
Figure 3C and D treatment with the Stat3 inhibitor, CPA7
for 15 hrs [25], or knockdown with a Stat3-specific, shRNA,
essentially eliminated Stat3, tyr705 phosphorylation and ac-
tivity in A549 cells. However, CPA7 treatment (Figure 2B,
d-f), or Stat3 knockdown (Figure 2B, g-i) did not increase
junctional permeability in A549 cells. Similar results were
obtained with SK-Lu1, CALU-1, SW-900 and CALU-6
lines (Table 1,B). The above data taken together indicate
that the high Stat3 activity, which could be, at least in part,
due to high Src activity in these lines, cannot be responsible
Figure 3 Primary lung carcinoma cells display low gap
junctional, intercellular communication. a and b: Cells cultured
from a freshly explanted lung tumor specimen were grown in
electroporation chambers and Lucifer yellow introduced with an
electrical pulse (Figure 7, [42]). Arrows point to the edge of the
electroporated area. Note the absence of gap junctional
communication. Magnification: 240x. c and d: Following growth of the
cells for 10 weeks, fibroblasts present in the original cell suspension
predominated. They were plated in electroporation chambers and
Lucifer yellow introduced with an electrical pulse. Note the extensive
communication through gap junctions. Lower panel Extracts of cells
cultured from a moderately differentiated adenosquamous carcinoma,
a poorly differentiated adenocarcinoma, and adenocarcinoma,
respectively (lanes 1–3), or E10 cells (lane 4), were probed for
Src-ptyr418 or GAPDH as a loading control, as indicated.
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cinoma lines examined.
Since the lung cancer lines might express other
oncogenes besides Src, we examined the role of Stat3




carcinoma cells 0.1 ±0.1
fibroblasts 5.8±1.2
Adenocarcinoma, poorly differentiated carcinoma cells 0.1 ±0.1
Adenocarcinoma carcinoma cells 0.1 ±0.1
αImmediately after surgery, cells were placed in culture and GJIC examined
(see Methods, Figure 7). After 8-10 weeks in culture, most of the tumor cells
had died while the fibroblasts present in the initial suspension predominated.
These cells did not express cytokeratins, contrary to tumor cells [18]. The
fibroblasts shown were derived from the moderately differentiated
adenosquamous carcinoma tumor above (Figure 3, c-d). GJIC was examined
as in Table I, at 3 days after confluence.the Src-transduced, SK-LuCi6-Src line. As expected,
Src expression disrupted gap junctional permeability.
Interestingly, subsequent Stat3 inhibition with CPA7 or
shRNA did not restore GJIC (Table 1,B). Taken together,
the above findings indicate that Stat3 cannot be part of a
pathway leading to Src-induced, gap junction closure in
SK-LuCi6-Src cells.
We then examined the possibility that Stat3 might play
a positive role in the maintenance of gap junctional
permeability, by assessing the effect of Stat3 inhibition
upon GJIC levels in QU-DB cells which have low Src
activity and extensive GJIC. As shown in Figure 2A (d-f),
Stat3 downregulation through CPA7 treatment essentially
abolished GJIC in QU-DB cells. Reduction of Stat3 levels
through infection with the sh-Stat3 lentivirus vector
gave similar results (Figure 2A, g-i). Similarly, Stat3
downregulation in SK-LuCi6 or E10 cells caused a
dramatic decrease in GJIC (Table 1,A). Conversely,
expression of the constitutively active form of Stat3,
Stat3C [26], increased the already extensive gap junctional
communication in SK-LuCi6 cells (Table 1,A).
Examination of Cx43 levels following sh-Stat3 expression
revealed a dramatic reduction (Figure 4B), indicating that
Stat3 is required for the maintenance of Cx43 protein
levels. TUNEL staining revealed that Stat3 inhibition by
CPA7 treatment caused an increase in apoptosis in
SK-LuCi6 cells (Figure 6A). In addition, CPA7 treatment
caused an increase in PARP cleavage in these cells, even at
a confluence of 50% (Figure 6B, lane 2). At 3 days post
confluence, the time of GJIC examination, PARP cleavage
was greater (lane 4), in agreement with previous results
indicating that Stat3 inhibition causes apoptosis which is
more pronounced in confluent cultures [27]. This finding
hints at a link between GJIC reduction and apoptosis
induced by Stat3 inhibition.
We next examined whether Stat3 inhibition might also
affect Cx43 mRNA levels, through quatitative RT-PCR
analysis [28]. The results showed that Stat3 inhibition by
CPA7 treatment, or downregulation through shRNA
expression brought about a substantial reduction in
Cx43 mRNA levels, indicating an effect of Stat3 upon
Cx43 gene transcription as well. In any event, taken
together, our data reveal that, rather than increasing
junctional permeability as might have been expected
based on the well documented ability of Stat3 to act
as a Src effector, Stat3 inhibition eliminates GJIC,
indicating that Stat3 activity is actually required for
gap junction function in two cultured lung carcinoma
lines which display extensive GJIC.
Discussion
Extensive data from our group and others demonstrated
that oncogenes such as mT, Src or Ras can suppress gap
junctional, intercellular communication [3,6]. Moreover,
Figure 4 A: Cell density causes a dramatic increase in Cx43 levels in QU-DB cells. QU-DB (lanes 5-8) or A549 (lanes 1-4) or nontransformed
E10 (lane 9) cells were grown to different densities as indicated and extracts probed for Cx43 or Hsp90 as a loading control. Note the absence of
Cx43 in A549 cells and the increase in Cx43 with density in QUDB. B: Stat3 knockdown reduces Cx43 levels. QU-DB cells infected with the
lentiviral vector carrying the Stat3-specific shRNA (lane 2) or not infected (lane 1) were grown to 2 days post-confluence and lysates probed for
Cx43 or Hsp90 as a loading control. C: CPA7 or Stat3-knockdown with shRNA reduce Stat3-ptyr705 levels in A549 cells. A549 cells were
grown to increasing densities and treated with the Stat3 inhibitor, CPA7 (lanes 6-8) or the DMSO carrier (lanes 1-5) for 15 hrs and cell extracts
probed for Stat3-ptyr705 or tubulin as a loading control. Parallel cultures were infected with a vector expressing a Stat3-specific, shRNA [37], and
cell extracts from stable lines produced were probed as above. D: CPA7 or Stat3-knockdown with shRNA reduce Stat3 transcriptional
activity in A549 cells. A549 cells were transfected with a plasmid expressing a firefly luciferase gene under control of a Stat3-responsive promotor
(▪) and a Stat3-independent promotor driving a Renilla luciferase gene (□) (see Methods). After transfection, cells were plated to different densities and
treated with CPA7 or the DMSO carrier alone for 24 hrs, at which time firefly and Renilla luciferase activities were determined. Parallel cultures
expressing the sh-Stat3 construct were transfected with the plasmids and firefly and Renilla luciferase activities determined.
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were sufficient to eliminate gap junction function than
the levels necessary for full transformation [4,29], indi-
cating that a decrease in GJIC may be an early event in
neoplastic conversion. In this communication we used
an improved procedure to examine GJIC in lung cancer
lines as well as in primary lung tumor cells. All cell lines
had been established from NSCLC tumors which were
known to be metastatic [18], except QU-DB, which was
derived from a patient that was a long term survivor
[30]. Our results reveal that GJIC was low in the major-
ity of cases, except in the QU-DB and SK-LuCi6 lines.
Assuming that the establishment process did not bring
about an increase in GJIC, the existence of extensive
GJIC in line SK-LuCi6 which was established from a rap-
idly metastatic tumor [31] indicates that intercellularcommunication does not necessarily inhibit metastasis;
other factors may supercede potential growth inhibitory
effects of intercellular communication and may be re-
sponsible for tumor growth and metastasis.
We next examined the mechanism of GJIC sup-
pression by assessing the role of Src and its effector
Stat3. Our results revealed an inverse relationship
between Src-tyr418 phosphorylation levels and GJIC
in a number of lines. Since Src is known to suppress
gap junctional communication in cultured cells such
as rodent fibroblasts and epithelial cells, it is tempt-
ing to speculate that Src may be responsible, at least
in part, for gap junction closure in these lines. How-
ever, repeated attempts to reinstate GJIC by reducing
Src activity levels through treatment with the Src
kinase family-selective, pharmacological inhibitors
Figure 5 A: A549 cells have high Src-ptyr418 levels. QU-DB (lanes 5-8) or A549 (lanes 1-4) cells were grown to different densities as indicated
and extracts probed for Src-ptyr418, Stat3-ptyr705 or total Src. Note the low levels of Src-ptyr418 in QU-DB cells. B: Src-ptyr418 and Stat3-
ptyr705 in NSCLC lines. The indicated cell lines were grown to 50% confluence and extracts probed for Src-ptyr418, Stat3-ptyr705, total Src or
GAPDH as a loading control. C: Dasatinib reduces Stat3-ptyr705 levels in A459 cells: A549 or SK-LuCi6-Src cells were grown to subconfluence
and treated with the Src-selective inhibitor, Dasatinib (1μM) or the DMSO carrier alone and cell extracts probed for Src-ptyr418, Stat3-ptyr705 or
GAPDH as a loading control, as indicated.
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Adenoviral vectors expressing a Src dominant-
negative mutant or c-Src kinase [15] in A549 cells
which have high Src-ptyr418 were unsuccessful (not
shown). Possibly other oncoproteins besides Src, or
other factors may be important contributors to GJIC
suppression in these lines. Alternatively, since low
levels of activated Src were previously shown to be
sufficient for GJIC suppression in mouse fibroblasts[3,4], the possibility that the residual Src activity in
treated cells might be sufficient to interrupt gap
junctional communication cannot be excluded. Dasati-
nib treatment of SK-LuCi6-Src cells did cause a partial
restoration of GJIC, although the high levels of SK-LuCi6
were not attained, possibly due to the high Src activity
levels in this line.
We also examined GJIC in freshly explanted, pri-
mary cells from 3 NSCLC specimens. Since the
Figure 6 A, B: Stat3 inhibition induces apoptosis A: SK-LuCi6 cells
without (a,b) or with (c,d) CPA7 treatment were fixed and stained for
TUNEL using FITC-coupled, nucleotide triphosphates (see Methods). B:
Extracts from SK-LuCi6 cells grown to 50% confluence or 3 days post-
confluence, without (lanes 1,3) or with (lanes 2,4) treatment with 50 μM
CPA7 for 15 hrs as indicated, were probed for cleaved PARP, with Hsp90
as a loading control (lower panel). C: Stat3 inhibition reduces Cx43
mRNA. Total RNA from SK-LuCi6 cells treated with the CPA7, Stat3
inhibitor, or the DMSO carrier alone, or stably expressing shStat3 as
indicated, was subjected to quantitative RT-PCR analysis (see Methods).
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plated in electroporation chambers immediately after
surgery at densities of ~80%, so that they would
reach confluence within 1–2 days, and GJIC exam-
ined every day for up to 10 days. No gap junctional
communication was ever detected in any of the pre-
parations, although fibroblasts from the same tissue
had extensive GJIC (Figure 3, c-d). Src-418 levels
were relatively high in cells from all three tumor
specimens, indicating that Src may have played a
role in GJIC suppression. However, the possibility
that the initiation of the senescence process even aday after surgery may have affected GJIC cannot be
excluded.
Stat3 does not transmit Src signals to gap junction
closure
Several signal transducers besides Stat3 are known to be
downstream effectors of the Src kinase such as Ras/Raf/
Erk, PI3k/Akt, the Crk-associated substrate (Cas) and
others [33]. Constitutively active Ras is neoplastically
transforming and can suppress GJIC [6,29]. Examination
of the mechanism of Src-mediated, GJIC suppression pre-
viously indicated that inhibition of Ras in Src-transformed,
rat fibroblasts reinstated gap junctional communication
[19]. Conversely, mT expression in Ras-deficient cells did
not suppress GJIC [34]. These data taken together under-
line the importance of the Ras pathway in GJIC reduction
by activated Src. It was also shown later that Cas is
required for the Src-induced, reduction in gap junctional
communication [35]. In sharp contrast, our present data
with Src-transduced, SK-LuCi6-Src cells demonstrate that
Stat3 inhibition does not restore GJIC, indicating that a
role of Stat3 in the Src-induced, GJIC suppression in these
cells is unlikely, despite the fact that constitutively active
Stat3 can act as an oncogene and transform established
lines [36].
Stat3 plays a positive role in gap junctional
communication
The fact that cell density upregulates Stat3 concomitant
with an increase in both Cx43 and GJIC prompted us to
explore a potential positive role of Stat3 upon GJIC. Inte-
restingly, Stat3 inhibition in two NSCLC lines which exhibit
extensive junctional communication (QU-DB, SK-LuCi6)
abolished GJIC, indicating that Stat3 does in fact play
a positive role in the maintenance of gap junction
function. This conclusion is in agreement with a previous
report indicating that Stat3 inhibition eliminated GJIC in
nontransformed rat liver epithelial cells as well [37].
Results from a number of labs demonstrated that Stat3
activates a number of anti-apoptotic genes, such as BcL-xL,
Mcl1 and Akt1 [11]. Global induction of apoptosis with
etoposide, cycloheximide or puromycin was shown to lead
to a loss of cell coupling, probably due to caspase-3-
mediated degradation of Cx43, in primary bovine lens
epithelial and mouse NIH3T3 fibroblasts [38]. Interestingly,
we previously demonstrated that Stat3 inhibition in cells
transformed by Src or the Large Tumor antigen of Simian
Virus 40 leads to apoptosis [15,39], possibly due to activa-
tion of the transcription factor E2F family, potent apoptosis
inducers, by these oncogenes. Therefore, apoptosis induced
by Stat3 downregulation in cells with high Src may have
triggered gap junction closure.
We previously demonstrated that while Stat3 inhibition
in sparsely growing, normal mouse fibroblasts causes
Figure 7 Electroporation on two co-planar ITO electrodes,
formed by removing the ITO coating by chemical etching
A: Top view. Cells were grown on an ITO-coated slide from which
the coating was removed in a strip as shown. The two conductive
sides (a, f), serving as electrodes, were connected to the positive and
negative poles of the pulse generator (2) and (3). A nonconductive
barrier (5) divides the strip of bare glass in half and separates the
chamber into two sections. B: Side view. The slide with the cells
growing on the ITO coated and the bare glass regions is shown.
When electroporation buffer is added to the chamber to a level
above the height of the barrier (5) then an electrical path between
the electrodes (e and b) is formed. Note that the ITO layer (1a) is
shown with dramatically exaggerated thickness for clarity, although its
actual thickness is much less than the thickness of the cells (from [42]).
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optimal gap junction formation, Stat3 inhibition leads to
apoptosis [27]. Therefore, apoptosis induction through a re-
duction in Stat3 levels or activity could explain the dramatic
reduction in Cx43 and GJIC upon Stat3 pharmacological or
genetic inhibition, in lines with low Src activity. Still, our
results also demonstrate a substantial reduction in Cx43
mRNA levels upon Stat3 inhibition, pointing to a transcrip-
tional effect of Stat3 upon the Cx43 promotor in these
NSCLC lines, as previously demonstrated in other cell types
[28,40,41].
Conclusions
Our results demonstrate that Stat3 is not transmitting
Src signals leading to gap junction closure in the NSCLC
cell lines examined. In the contrary, although Stat3 is
generally growth promoting and in an activated form it
can act as an oncogene, we show for the first time that
Stat3 is actually required for gap junctional communica-
tion both in normal epithelial cells and in certain tumor
cell lines that retain GJIC. This novel role of Stat3 in gap
junction function may be an important regulatory step
in progression of tumours that exploit such a pathway.
Methods
Examination of gap junctional communication
To examine gap junctional communication by in situ
electroporation, it is important to be able to reliably
distinguish cells that were loaded with Lucifer yellow
directly by electroporation, from cells that received the
dye from neighbouring cells by diffusion through gap
junctions. This was achieved using a slide where a 3
mm-wide strip of ITO had been removed by etching
with acids, leaving two co-planar electrodes, supported
by the same glass slide substrate (Figure 7) [42].
In a further improvement (Figure 8), the coating was
removed from the glass surface in ~20 μm wide lines, to
define electrode and non-conducting regions. Etching was
done using a laser beam, so that the nonconductive glass
underneath is exposed. It was important to ensure that
only the 800Å coating was removed, without affecting the
glass, so that cell growth would be unaffected across the
line. This was achieved with a UV laser operating at a 355
nm wavelength using approximately 1 Watt of output
power with 60% of the energy delivered to the surface of
the glass. The beam was manipulated by mirrors on a pair
of galvanometers to produce the desired pattern.
To form the two electrodes, the coating was removed in
a straight line in the middle (2). A dam of nonconductive
plastic (3) was bonded onto this line, to divert the current
upwards, thus creating a sharp transition in electric field
intensity between electroporated and non-electroporated
sections. To provide areas where the cells are not electro-
porated, the ITO was also removed in two parallel lines[(4) and (4a)]. A plastic chamber was bonded onto the
slide, to form a container for the cells and electroporation
solutions (5). Current flows inwards from each contact
point (6 and 6a), via a conductive highway under the well
(5) electroporating cells in area (d) then over the barrier
[(8), arrowheads] to the other side, in area (a). In this con-
figuration, cells which acquired LY by electroporation
[growing in (a) and (d)] and cells into which LY traveled
through gap junctions [ (b) and (c)] both grow on ITO,
separated only by a laser-etched line of ~20 μm. Extensive
experimentation showed that in this setup the electropo-
ration intensity is uniform across the electroporated area
(see Figure 1B and Figure 2).
Cells were plated in the chamber and when they
reached the appropriate density (90% confluence, to 5
days post-confluence), the growth medium was replaced
with Calcium-free DMEM supplemented with 5 mg/ml
Lucifer yellow (7). The slide/chamber was placed into a
Figure 8 Electroporation on two co-planar ITO electrodes,
formed by removing the ITO coating by etching with Lasers.
A: Top view. Cells are grown on a glass slide (1), coated with ITO
(1a). The coating is laser-etched in a straight line in the middle (2),
essentially forming two electrodes. A dam of Teflon (3) is used to
divert the current upwards, thus creating a sharp transition in
electric field intensity. A plastic chamber is bonded onto the slide,
to form a container for the cells and LY (5). To provide areas where
the cells are not electroporated, the ITO was also removed in two
parallel lines [(4), (4a)]. Current from a pulse generator flows
inwards from each contact point (6 and 6a) to area (d) then over
the barrier [(3), arrowheads] to the other side, electroporating cells
in area (a). For clarity, the front part of the chamber is removed. B:
Side view. The slide (1) with the cells growing on the ITO coated
[(1a), light green] and etched, bare glass regions is shown. When
electroporation medium (7) is added to the chamber to a level above
the height of the dam (3) then an electrical path (arrowheads)
between the electrodes (6) and (6a) and the cells (9) growing in this
area is formed. Note that the size of the cells and the ITO layer (1a) are
shown exaggerated for clarity although the actual thickness of the ITO
(800 Å) is much lower than the thickness of the cells.
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set of electrical pulses delivered to the cells. Extensive
experimentation indicated that 10 pulse pairs, each pulse of
18 Volts peak value, 100 μs length and spaced 0.5 seconds
apart, with one of each pair having a polarity opposite to
that of its partner gave optimal results. Following a 5 min
incubation at 37°C, the unincorporated dye was washed
away with Calcium-free DMEM supplemented with10% dialysed fetal calf serum and cells observed and photo-
graphed under fluorescence and phase contrast illumi-
nation. Communication is expressed as the number of cells
into which the dye has transferred per cell loaded with the
dye by electroporation at the edge of the electroporated
area. All experiments were conducted at least three times,
with at least 5 slides each time, and the results are
presented as average GJIC±SEM where the transfer from at
least 200 cells is assessed.
The equipment (Insitu Porator) was supplied by Cell
Projects Ltd UK.Cell lines, culture techniques and Stat3 activity
measurement
All cells were grown in DMEM with 10% fetal calf serum.
Extra care was taken to ensure that cell seeding was uni-
form, by passing cells at subconfluence, when cell to cell
adhesion was low. Confluence was estimated visually and
quantitated by imaging analysis of live cells under phase
contrast [14]. To ensure that the growth medium was not
depleted of nutrients, it was changed every day.
Cells were cultured from surgically explanted tumors
as previously described [18].
Stat3C and activated Src were expressed in SK-LuCi-6
cells through infection with the culture supernatant from
a Phoenix amphotropic packaging line transfected with a
pBabe-puro-Stat3C plasmid [26]. shStat3 was expressed
by retroviral vector infection as described [16].
Stat3 transcriptional activity was measured as described,
by transient transfection of the pLucTKS3 construct [24].
As a control, cells were co-transfected with the reporter
pRLSRE, which contains two copies of the serum response
element (SRE) of the c-fos promoter, subcloned into the
Renilla luciferase reporter, pRL-null (Promega) [15].
Following transfection, cells were plated to different
densities and luciferase activity determined.
For Stat3 immunostaining, SK-LuCi6 cells were fixed
with 4% paraformaldehyde, permeabilized in 0.2% Triton-
X100 and probed with a Stat3 antibody (Cell Signalling,
#9132 diluted at 1:100) followed by AlexaFluor-coupled,
goat anti-rabbit IgG (Invitrogen #A11008, used at 1:400).Inhibitors
Stat3 was inactivated using two approaches: (1). Treatment
with 50 μM CPA7 [PtCl3(NO2)(NH3)2] [25] overnight, or
(2). Expression of shRNA, delivered with a lentivirus
vector as described [37]. Jak inhibitor-1 was from
EMD Biosciences (5 μM [16]).
Src was inactivated using 3 pharmacological inhibitors:
Dasatinib (0.5 or 1 μM, up to 72h), PD180970 (0.2 μM
with redosing every 12h for a total of 24h), or SU6656
(5μM for 24h) [15].
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It was conducted on proteins extracted from cell pellets
[43], using antibodies to Cx43 (Cell Signalling, #3512, used
at a 1:500 dilution), Stat3-ptyr705 (Cell Signalling, #9131,
1:1,000), Src-ptyr418 (Invitrogen, #44-660G , 1:1,000) or
total Src (rabbit monoclonal 36D10, Cell Signalling, #2109,
1:1,000), followed by secondary antibodies and ECL
reagents (Biosource). Alpha-Tubulin (Cell Signalling #2125,
1:5,000), GAPDH (BD Transduction, #14C10, 1:5,000)
or Hsp90 (Assay designs, #SPA-830, 1:5,000) served
as loading controls.
qRT-PCR
SK-LuCi6 cells were treated with CPA7 for 15 hrs. The
RNeasy Mini Kit (Qiagen, Hilden Germany, cat. #74104)
was used for the purification of RNA. cDNA synthesis
from 1μg of total RNA was performed using the iScript
cDNA synthesis kit (Bio-RAD Laboratories, Hercules, CA).
qRT-PCR was performed using iQ SYBR Green Supermix
(Bio-RAD Laboratories, Hercules, CA) and 20μM primer.
Primer sequences were [28]:
Cx43: Forward: 50-GCCTGAACTTGCCTTTTCAT-30,
Reverse: 50- CTCCAGTCACCCATGTTGC-30, [28] to
generate a product of 500 bp [40].
As internal reference genes we used GAPDH: (for-
ward: 50-AATGCATCCTGCACCACCAA-30, Reverse:
50-GTAGCCATATTCATTGTCATA-30) [40] and 18S RNA
[16]. mRNA from SK-LuCi6 cells where Stat3 was downre-
gulated with sh-Stat3 was analysed in a similar manner.
Results from 3 independent experiments, each conducted
in triplicate were averaged out and SEM calculated.
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